院内感染制御感染症の世界市場 2020年

• 英文タイトル：Global Healthcare-Acquired Infection Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115563 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、院内感染制御感染症の世界市場を調査対象にし、院内感染制御感染症の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（医薬品治療、環境治療、医療機器管理）、用途別分析（病院、診療所、外来手術センター、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Pfizer、Sanofi、Novartis、Hologic、Roche、BD、Abbott ・企業別売上、市場シェア ・院内感染制御感染症の地域別市場分析 ・院内感染制御感染症の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・院内感染制御感染症のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・院内感染制御感染症のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・院内感染制御感染症の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・院内感染制御感染症の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・院内感染制御感染症の種類別市場規模2015-2020：医薬品治療、環境治療、医療機器管理 ・院内感染制御感染症の用途別市場規模2015-2020：病院、診療所、外来手術センター、その他 ・院内感染制御感染症の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Healthcare-Acquired Infection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Healthcare-Acquired Infection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Healthcare-Acquired Infection market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Healthcare-Acquired Infection market has been segmented into:
Pharmaceutical Treatment
Environment Treatment
Medical Devices Management

By Application, Healthcare-Acquired Infection has been segmented into:
Hospital
Clinics
Ambulatory Surgery Centers
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Healthcare-Acquired Infection market presented in the report. This section sheds light on the sales growth of different regional and country-level Healthcare-Acquired Infection markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Healthcare-Acquired Infection market.

The report offers in-depth assessment of the growth and other aspects of the Healthcare-Acquired Infection market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Healthcare-Acquired Infection Market Share Analysis
Healthcare-Acquired Infection competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Healthcare-Acquired Infection sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Healthcare-Acquired Infection sales, revenue and market share for each player covered in this report.

The major players covered in Healthcare-Acquired Infection are:
Pfizer
Sanofi
Novartis
Hologic
Roche
BD
Abbott

レポート目次

---

1 Healthcare-Acquired Infection Market Overview
1.1 Product Overview and Scope of Healthcare-Acquired Infection
1.2 Classification of Healthcare-Acquired Infection by Type
1.2.1 Global Healthcare-Acquired Infection Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Healthcare-Acquired Infection Revenue Market Share by Type in 2019
1.2.3 Pharmaceutical Treatment
1.2.4 Environment Treatment
1.2.5 Medical Devices Management
1.3 Global Healthcare-Acquired Infection Market by Application
1.3.1 Overview: Global Healthcare-Acquired Infection Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers
1.3.5 Others
1.4 Global Healthcare-Acquired Infection Market by Regions
1.4.1 Global Healthcare-Acquired Infection Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Healthcare-Acquired Infection (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Healthcare-Acquired Infection Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Healthcare-Acquired Infection Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Healthcare-Acquired Infection Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Healthcare-Acquired Infection Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Healthcare-Acquired Infection Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2018-2019)
2.4 Hologic
2.4.1 Hologic Details
2.4.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Hologic SWOT Analysis
2.4.4 Hologic Product and Services
2.4.5 Hologic Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2018-2019)
2.6 BD
2.6.1 BD Details
2.6.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BD SWOT Analysis
2.6.4 BD Product and Services
2.6.5 BD Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abbott SWOT Analysis
2.7.4 Abbott Product and Services
2.7.5 Abbott Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Healthcare-Acquired Infection Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Healthcare-Acquired Infection Players Market Share
3.2.2 Top 10 Healthcare-Acquired Infection Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Healthcare-Acquired Infection Revenue and Market Share by Regions
4.2 North America Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
4.3 Europe Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
4.5 South America Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
5 North America Healthcare-Acquired Infection Revenue by Countries
5.1 North America Healthcare-Acquired Infection Revenue by Countries (2015-2020)
5.2 USA Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
5.3 Canada Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
5.4 Mexico Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
6 Europe Healthcare-Acquired Infection Revenue by Countries
6.1 Europe Healthcare-Acquired Infection Revenue by Countries (2015-2020)
6.2 Germany Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
6.3 UK Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
6.4 France Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
6.5 Russia Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
6.6 Italy Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Healthcare-Acquired Infection Revenue by Countries
7.1 Asia-Pacific Healthcare-Acquired Infection Revenue by Countries (2015-2020)
7.2 China Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
7.3 Japan Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
7.4 Korea Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
7.5 India Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
8 South America Healthcare-Acquired Infection Revenue by Countries
8.1 South America Healthcare-Acquired Infection Revenue by Countries (2015-2020)
8.2 Brazil Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
8.3 Argentina Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Healthcare-Acquired Infection by Countries
9.1 Middle East & Africa Healthcare-Acquired Infection Revenue by Countries (2015-2020)
9.2 Saudi Arabia Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
9.3 UAE Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
9.4 Egypt Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
9.5 South Africa Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Healthcare-Acquired Infection Revenue and Market Share by Type (2015-2020)
10.2 Global Healthcare-Acquired Infection Market Forecast by Type (2019-2024)
10.3 Pharmaceutical Treatment Revenue Growth Rate (2015-2025)
10.4 Environment Treatment Revenue Growth Rate (2015-2025)
10.5 Medical Devices Management Revenue Growth Rate (2015-2025)
11 Global Healthcare-Acquired Infection Market Segment by Application
11.1 Global Healthcare-Acquired Infection Revenue Market Share by Application (2015-2020)
11.2 Healthcare-Acquired Infection Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgery Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Healthcare-Acquired Infection Market Size Forecast (2021-2025)
12.1 Global Healthcare-Acquired Infection Market Size Forecast (2021-2025)
12.2 Global Healthcare-Acquired Infection Market Forecast by Regions (2021-2025)
12.3 North America Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
12.4 Europe Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
12.6 South America Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Healthcare-Acquired Infection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Healthcare-Acquired Infection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Healthcare-Acquired Infection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Healthcare-Acquired Infection Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Healthcare-Acquired Infection Major Business
Table 7. Pfizer Healthcare-Acquired Infection Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Healthcare-Acquired Infection Product and Solutions
Table 10. Pfizer Healthcare-Acquired Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Healthcare-Acquired Infection Major Business
Table 13. Sanofi Healthcare-Acquired Infection Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Healthcare-Acquired Infection Product and Solutions
Table 16. Sanofi Healthcare-Acquired Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Healthcare-Acquired Infection Major Business
Table 19. Novartis Healthcare-Acquired Infection Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Healthcare-Acquired Infection Product and Solutions
Table 22. Novartis Healthcare-Acquired Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Hologic Corporate Information, Location and Competitors
Table 24. Hologic Healthcare-Acquired Infection Major Business
Table 25. Hologic Healthcare-Acquired Infection Total Revenue (USD Million) (2017-2018)
Table 26. Hologic SWOT Analysis
Table 27. Hologic Healthcare-Acquired Infection Product and Solutions
Table 28. Hologic Healthcare-Acquired Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Roche Corporate Information, Location and Competitors
Table 30. Roche Healthcare-Acquired Infection Major Business
Table 31. Roche Healthcare-Acquired Infection Total Revenue (USD Million) (2017-2018)
Table 32. Roche SWOT Analysis
Table 33. Roche Healthcare-Acquired Infection Product and Solutions
Table 34. Roche Healthcare-Acquired Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. BD Corporate Information, Location and Competitors
Table 36. BD Healthcare-Acquired Infection Major Business
Table 37. BD Healthcare-Acquired Infection Total Revenue (USD Million) (2017-2018)
Table 38. BD SWOT Analysis
Table 39. BD Healthcare-Acquired Infection Product and Solutions
Table 40. BD Healthcare-Acquired Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Abbott Corporate Information, Location and Competitors
Table 42. Abbott Healthcare-Acquired Infection Major Business
Table 43. Abbott Healthcare-Acquired Infection Total Revenue (USD Million) (2017-2018)
Table 44. Abbott SWOT Analysis
Table 45. Abbott Healthcare-Acquired Infection Product and Solutions
Table 46. Abbott Healthcare-Acquired Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Healthcare-Acquired Infection Revenue (Million USD) by Players (2015-2020)
Table 48. Global Healthcare-Acquired Infection Revenue Share by Players (2015-2020)
Table 49. Global Healthcare-Acquired Infection Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Healthcare-Acquired Infection Revenue Market Share by Regions (2015-2020)
Table 51. North America Healthcare-Acquired Infection Revenue by Countries (2015-2020)
Table 52. North America Healthcare-Acquired Infection Revenue Market Share by Countries (2015-2020)
Table 53. Europe Healthcare-Acquired Infection Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Healthcare-Acquired Infection Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Healthcare-Acquired Infection Revenue by Countries (2015-2020)
Table 56. South America Healthcare-Acquired Infection Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Healthcare-Acquired Infection Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Healthcare-Acquired Infection Revenue Market Share by Countries (2015-2020)
Table 59. Global Healthcare-Acquired Infection Revenue (Million USD) by Type (2015-2020)
Table 60. Global Healthcare-Acquired Infection Revenue Share by Type (2015-2020)
Table 61. Global Healthcare-Acquired Infection Revenue Forecast by Type (2021-2025)
Table 62. Global Healthcare-Acquired Infection Revenue by Application (2015-2020)
Table 63. Global Healthcare-Acquired Infection Revenue Share by Application (2015-2020)
Table 64. Global Healthcare-Acquired Infection Revenue Forecast by Application (2021-2025)
Table 65. Global Healthcare-Acquired Infection Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Healthcare-Acquired Infection Picture
Figure 2. Global Healthcare-Acquired Infection Revenue Market Share by Type in 2019
Figure 3. Pharmaceutical Treatment Picture
Figure 4. Environment Treatment Picture
Figure 5. Medical Devices Management Picture
Figure 6. Healthcare-Acquired Infection Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinics Picture
Figure 9. Ambulatory Surgery Centers Picture
Figure 10. Others Picture
Figure 11. Global Healthcare-Acquired Infection Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Healthcare-Acquired Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Healthcare-Acquired Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Healthcare-Acquired Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Healthcare-Acquired Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Healthcare-Acquired Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Healthcare-Acquired Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Healthcare-Acquired Infection Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Healthcare-Acquired Infection Revenue Market Share in 2019
Figure 20. Global Top 10 Players Healthcare-Acquired Infection Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Healthcare-Acquired Infection Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Healthcare-Acquired Infection Revenue Market Share by Regions (2015-2020)
Figure 24. Global Healthcare-Acquired Infection Revenue Market Share by Regions in 2018
Figure 25. North America Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 26. Europe Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 28. South America Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 30. North America Healthcare-Acquired Infection Revenue Market Share by Countries (2015-2020)
Figure 31. North America Healthcare-Acquired Infection Revenue Market Share by Countries in 2019
Figure 32. USA Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 33. Canada Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 35. Europe Healthcare-Acquired Infection Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Healthcare-Acquired Infection Revenue Market Share by Countries in 2019
Figure 37. Germany Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 38. UK Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 39. France Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 40. Russia Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 41. Italy Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Healthcare-Acquired Infection Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Healthcare-Acquired Infection Revenue Market Share by Countries in 2019
Figure 44. China Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 45. Japan Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 46. Korea Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 47. India Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 49. South America Healthcare-Acquired Infection Revenue Market Share by Countries (2015-2020)
Figure 50. South America Healthcare-Acquired Infection Revenue Market Share by Countries in 2019
Figure 51. Brazil Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Healthcare-Acquired Infection Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Healthcare-Acquired Infection Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 56. UAE Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Healthcare-Acquired Infection Revenue and Growth Rate (2015-2020)
Figure 59. Global Healthcare-Acquired Infection Revenue Share by Type (2015-2020)
Figure 60. Global Healthcare-Acquired Infection Revenue Share by Type in 2019
Figure 61. Global Healthcare-Acquired Infection Market Share Forecast by Type (2021-2025)
Figure 62. Global Pharmaceutical Treatment Revenue Growth Rate (2015-2020)
Figure 63. Global Environment Treatment Revenue Growth Rate (2015-2020)
Figure 64. Global Medical Devices Management Revenue Growth Rate (2015-2020)
Figure 65. Global Healthcare-Acquired Infection Revenue Share by Application (2015-2020)
Figure 66. Global Healthcare-Acquired Infection Revenue Share by Application in 2019
Figure 67. Global Healthcare-Acquired Infection Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospital Revenue Growth Rate (2015-2020)
Figure 69. Global Clinics Revenue Growth Rate (2015-2020)
Figure 70. Global Ambulatory Surgery Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Healthcare-Acquired Infection Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Healthcare-Acquired Infection Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Healthcare-Acquired Infection Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
Figure 76. Europe Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
Figure 78. South America Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Healthcare-Acquired Infection Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---